Skip to main content


You are here

UM Ventures and SilcsBio, LLC Announce Licensing Agreement

Thursday, June 6, 2013

BALTIMORE, MD, June 6, 2013 – University of Maryland (UM) Ventures and SilcsBio, LLC announced today that SilcsBio has obtained exclusive rights to a technology licensed from the University of Maryland, Baltimore (UMB). UM Ventures is an ambitious joint research commercialization effort of the UMB and the University of Maryland, College Park (UMCP). SilcsBio is a supplier of computer-directed drug discovery software and services.

"The license, which we obtained from UMB, creates the core of our product line," said Kelli Booth, SilcsBio’s Chief Operating Officer. “It’s great to have a university so supportive of our state’s start-up community.”

As covered by the Baltimore Business Journal: SilcsBio inks licensing deal with University of Maryland, Baltimore -- Read article at